Envista Holdings Corporation (NYSE: NVST) has shown a modest gain of approximately 1.20%, indicating a steady upward trend.The stock has experienced a recent dip of about 4.42%, potentially offering a buying opportunity for investors.Envista boasts a strong growth potential with an estimated stock price growth potential of 23.39% and a robust Piotroski Score of 8.Envista Holdings Corporation (NYSE: NVST) is a prominent player in the dental products industry. The company specializes in providing a wide range ...

Core Insights - Erste Group Bank raised its annual targets following third-quarter results that exceeded expectations, driven by loan growth and reduced customer deposit costs, resulting in a record high for its shares [1] Financial Performance - The third-quarter results showed significant loan growth, which contributed positively to the bank's performance [1] - Lower customer deposit costs also played a crucial role in enhancing the bank's financial results [1] Market Reaction - The positive earnings report and raised targets led to Erste Group Bank's shares reaching a record high [1]

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Envista (NYSE:NVST) Q3 2025 Earnings Call October 30, 2025 05:00 PM ET Speaker2Hello, my name is Sergio, and I will be your conference call facilitator this afternoon. At this time, I would like to welcome everyone to Envista Holdings Corporation's Third Quarter 2025 Earnings Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during that time, please press S ...

Core Insights - Envista Holdings Corporation is a significant player in the dental products industry, offering a variety of solutions across segments such as orthodontics, implants, and digital imaging, while facing competition from companies like Dentsply Sirona and Align Technology [1] Financial Performance - For the third quarter of 2025, Envista reported strong financial results, with core growth, adjusted EBITDA, and adjusted EPS exceeding expectations, highlighting positive growth across all major business segments [3][6] - The company achieved an operating cash flow of $79 million and a free cash flow of $68 million for the third quarter, marking increases from the previous year's $71 million and $63 million, respectively [4][6] - Envista repurchased 2.1 million shares for approximately $41 million during the same period [4][6] Stock Performance and Analyst Ratings - As of October 30, 2025, Jonathan Block from Stifel Nicolaus set a price target of $25 for NVST, indicating a potential increase of about 22.73% from its trading price of $20.37 [2][6] - Currently, NVST is priced at $19.92, reflecting a slight decrease of 0.3%, with a market capitalization of approximately $3.31 billion [5]

We partner with dental professionals to improve patients' lives Q3 2025 Results 01/01/2025 October 30, 2025 1 Forward looking statements/Non-GAAP financial measures FORWARD-LOOKING STATEMENTS Certain statements in this presentation are "forward-looking statements" within the meaning of the U.S. federal securities laws, including statements regarding future financial performance, and the objectives and expectations of management. Terminology such as "believe," "anticipate," "should," "could," "intend," "will ...

Core Viewpoint - Envista Holdings Corporation reported strong financial results for Q3 2025, exceeding expectations in core growth, adjusted EBITDA, and adjusted EPS, with positive growth across all major business segments [2][6]. Financial Highlights - Q3 2025 sales reached $670 million, reflecting a core sales growth of 9.4% compared to Q3 2024 [6]. - The company reported a GAAP net loss of $30 million, attributed to a tax charge from restructuring intercompany loans, while adjusted net income was $54 million [3][6]. - Adjusted EBITDA for the quarter was $97 million, representing a 77% increase year-on-year, with an adjusted EBITDA margin of 14.5%, up 540 basis points from the previous year [6]. - For the first nine months of 2025, sales totaled $1,969 million, with a core sales growth of 5.0% compared to the same period in 2024 [6]. Cash Flow and Share Repurchases - Operating cash flow for Q3 2025 was $79 million, and free cash flow was $68 million, compared to $71 million and $63 million in Q3 2024, respectively [4]. - During the quarter, the company repurchased 2.1 million shares for approximately $41 million, with $108 million remaining under its stock repurchase program [4]. Outlook - Envista updated its full-year 2025 guidance, projecting core sales growth of approximately 4%, an adjusted EBITDA margin of around 14%, and adjusted diluted earnings per share between $1.10 and $1.15 [5][6]. Business Segment Performance - Specialty Products & Technologies segment sales were $431.5 million, up from $381.7 million in Q3 2024, while Equipment & Consumables segment sales increased to $238.4 million from $219.3 million [15]. - Operating profit for the Specialty Products & Technologies segment was $48.1 million, significantly higher than $12.3 million in the prior year [15].

Financial Performance - Q3 2025 sales reached $670 million, representing a core sales growth of 9.4% compared to Q3 2024[4] - Adjusted EBITDA for Q3 2025 was $97 million, reflecting a 77% year-on-year increase, with an adjusted EBITDA margin of 14.5% (+540 bps year-on-year)[4] - The company reported a GAAP net loss of $30 million for Q3 2025, attributed to a tax charge from restructuring intercompany loans[4] - Adjusted diluted earnings per share (EPS) for Q3 2025 was $0.32, a 167% increase year-on-year[4] - Operating cash flow for Q3 2025 was $79 million, while free cash flow was $68 million, compared to $71 million and $63 million in Q3 2024, respectively[5] - Net income for the nine months ended September 26, 2025, was $14.1 million, a significant recovery from a net loss of $1,119.8 million in the same period last year[19] - Adjusted net income for the nine months ended September 26, 2025, was $138.9 million, compared to $85.4 million for the same period last year, indicating a growth of 62.6%[21] - Adjusted diluted EPS guidance for 2025 is now set at $1.10 to $1.15, an increase from the prior guidance of $1.05 to $1.15[7] Cash Flow and Share Repurchase - The company repurchased 2.1 million shares for approximately $41 million during the quarter, with $108 million remaining under its stock repurchase program[6] - Free cash flow for the nine months ended September 26, 2025, was $139.2 million, down from $178.9 million in the prior year, a decrease of 22.2%[21] - Free Cash Flow (FCF) for the three months ended September 26, 2025, was $67.9 million, compared to $63.3 million for the same period in 2024, representing a 10.0% increase[31] Sales and Growth - For full year 2025, the company updated its core sales growth guidance to approximately 4%, up from the previous range of 3% to 4%[7] - All major businesses delivered positive growth, supported by several new product launches[4] - Specialty Products & Technologies segment sales for the three months ended September 26, 2025, were $431.5 million, up from $381.7 million in the same period last year, an increase of 13.1%[23] - Total sales growth for the three months ended September 26, 2025, was 11.5%, with core sales growth contributing 9.4%[30] Assets and Liabilities - Total assets increased to $5,642.5 million as of September 26, 2025, up from $5,350.5 million at December 31, 2024, reflecting a growth of approximately 5.5%[17] - Total liabilities decreased to $2,554.3 million as of September 26, 2025, from $2,516.0 million at December 31, 2024, a reduction of approximately 1.5%[17] Operating Performance - Gross profit for the three months ended September 26, 2025, was $370.2 million, compared to $317.3 million for the same period last year, representing a year-over-year increase of 16.7%[21] - Adjusted Operating Profit for the three months ended September 26, 2025, was $85.6 million, up from $43.8 million for the same period in 2024, representing a 95.7% increase[25] - Adjusted Net Income for the three months ended September 26, 2025, was $53.7 million, compared to $21.1 million for the same period in 2024, reflecting a 153.1% increase[26] - The operating margin for the total segment improved to 8.6% for the three months ended September 26, 2025, compared to 3.5% in the same period last year[23] Non-GAAP Measures and Adjustments - Adjusted EBITDA is used as a supplemental measure for assessing operating performance, excluding interest, taxes, depreciation, amortization, and unusual losses or gains[35] - Free Cash Flow (FCF) is utilized to evaluate the company's ability to generate cash for investments and growth, although it does not account for debt service requirements[36] - The company excludes amortization of acquisition-related intangible assets to facilitate consistent comparisons of operating results over time[37] - Core sales exclude the effects of acquisitions, divested product lines, discontinued products, and currency translation to provide a clearer view of ongoing operations[37] - Adjusted Net Income and Adjusted Diluted Earnings Per Share are calculated after excluding items that may obscure underlying business trends[37] - Management uses non-GAAP measures to evaluate operating and financial performance, highlighting the limitations of Free Cash Flow[36] - The company aims to provide investors with insights into long-term profitability trends compared to peers and historical performance[35]

Core Insights - Envista Holdings Corporation released its 2024 Sustainability Report, emphasizing its commitment to sustainable and responsible business practices aimed at improving lives through partnerships with dental professionals [1][2]. Sustainability Initiatives - The report highlights key focus areas including expanding access to high-quality dental care, supporting colleagues and communities, environmental stewardship, and maintaining a strong ethical foundation [2][4]. - Envista donated $1.9 million in goods and services to enhance access to oral care health and education for underserved communities through the Envista Smile Project [7]. - The company completed its inaugural Scope 3 GHG emissions inventory to better manage its environmental footprint [7]. Performance Metrics - Envista achieved a 13% reduction in its safety incident rate, indicating improved workplace safety [7]. - The report reflects the collective efforts of teams across the organization, showcasing the company's dedication to creating lasting value for stakeholders [4]. Company Overview - Envista is a global family of over 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, focused on delivering innovative dental products and solutions [5]. - The company is positioned as one of the largest global dental products companies, with significant market presence in attractive segments of the dental industry [5].

Core Insights - Envista (NVST) has a strong history of beating earnings estimates and is well-positioned for continued success in upcoming reports [1][2] Earnings Performance - Envista has surpassed earnings estimates by an average of 14.17% over the last two quarters [2] - In the most recent quarter, Envista reported earnings of $0.26 per share against an expectation of $0.24, resulting in a surprise of 8.33% [2] - For the previous quarter, the consensus estimate was $0.20 per share, while the actual earnings were $0.24, leading to a surprise of 20.00% [2] Earnings Estimates and Predictions - Recent estimates for Envista have been increasing, indicating a positive outlook for future earnings [5] - The Zacks Earnings ESP for Envista is currently +1.62%, suggesting analysts are optimistic about its near-term earnings potential [8] - The combination of a positive Earnings ESP and a Zacks Rank of 3 (Hold) indicates a high likelihood of another earnings beat [5][8] Statistical Insights - Stocks with a positive Earnings ESP and a Zacks Rank of 3 or better have a nearly 70% chance of producing a positive surprise [6] - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, reflecting the latest analyst revisions [7]